Drugs, Devices, and Diagnostics
Latest | Media coverage | Commentary | Academic Literature | Legislation | Reports and Government Documents
Covering prescription medicines and medical devices, which includes instruments, implants, scans and tests, as well as screening and health promoting interventions.
Latest
Media coverage
Popular weight-loss drug Wegovy receives approval in New Zealand
A popular weight-loss drug used by celebrities overseas has been approved by New Zealand’s medicine regulatory body, with its producer hoping to make it accessible “as soon as possible”.
Medical Council working on new guidelines for use of AI
The Medical Council is expected to release new guidelines for the use of artificial intelligence before the end of the year, according to board member Stephen Child.
Years-long delays to access ‘life-changing’ diabetes technology
Thousands of New Zealanders living with type 1 diabetes face a frustrating wait for potentially life-changing technology, despite a recent announcement from Pharmac that continuous glucose monitors (CGMs) and insulin pumps are now fully funded.
Commentary
Ministry of Health Annual Report for the year ended 30 June 2024
The Annual Report for the year ended 30 June 2024 sets out who we are and what we do, how we manage our business, our financial statements and statement of service performance as specified in Vote Health – Main Estimates of Appropriation 2023/24 and (where updated) in Vote Health – Supplementary Estimates of Appropriation 2023/24.
Strategic Intentions 2024–2028 Ko ngā Takune-ā-Rautaki 2024–2028
The document sets out the Ministry’s own strategic focus, functions and priorities aligned and contributing to, but distinct from those of the Government.
MEMORANDUM-DIRECTIONS OF JUDGE D STONE CONCERNING NEXT STEPS IN THE TE AKA WHAI ORA PRIORITY INQUIRY
This memorandum-directions confirms next steps regarding the priority inquiry into the disestablishment of Te Aka Whai Ora (the Maaori Health Authority).
Academic Literature
Use of puberty-blocking hormones for gender dysphoria in New Zealand: descriptive analysis and international comparisons
The high rate of prescribing for probable gender dysphoria in New Zealand, and the decline after 2021, require further investigation.
Equity in national healthcare economic evaluation guidelines: Essential or extraneous?
Equity is given less attention than efficiency in HEE guidelines. This indicates that HTA agencies while subscribing to an extra-welfarist approach have a narrow evaluative space – focusing on maximising health and not considering the opportunity cost of the equity constraint.
Improving cervical screening rates among sexual minorities: Insights from Aotearoa New Zealand
The analysis showed that the inherent heteronormativity among health care professionals and the lack of clear and consistent information specific to sexual minority women may be key factors contributing to lower rates of engagement in screening.
Legislation and Parliament
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
Reports and Government Documents
Medicines Amendment Bill passes first reading
Associate Health Minister David Seymour is welcoming the passing of the Medicines Amendment Bill at first reading. The bill enables the ‘Rule of Two’. allowing medicines to be approved in less than 30 days if the product has approval from two recognised overseas jurisdictions.
Briefing to the Incoming Minister of Health January 2025
Following a change of Minister, the Ministry of Health | Manatū Hauora, produces a Briefing to the Incoming Minister of Health, as is usual practice.
Strategic Approach to Immunisation in New Zealand 2025–2030
Immunisation is a highly successful public health intervention. It safeguards individuals, whānau and communities against a range of potentially devastating diseases, and is a critical way of preventing and controlling infectious disease outbreaks. An accessible and effective immunisation system maximises immunisation uptake and coverage, improving the health of the population and enabling pae ora – healthy futures.
Key issues
HEALTH SERVICES AND SYSTEMS
EQUITY
DRUGS, DEVICE AND DIAGNOSTICS
PUBLIC HEALTH
DIGITAL HEALTH
TE TIRITI






